05th week of 2009 patent applcation highlights part 39 |
Patent application number | Title | Published |
20090028914 | MEDICAL DEVICES INCORPORATING COLLAGEN INHIBITORS - Provided herein are implantable or insertable biomedical devices comprising a substrate and a collagen inhibitor on or in said substrate, and methods of treatment using the same. In some embodiments, the device is an absorbable esophageal or tracheal stent. In some embodiments, the device is a vascular stent. Wound closure devices are also provided herein, including a substrate and a collagen inhibitor on or in the substrate. Also provided are surgical packings, including a substrate and a collagen inhibitor on or in the substrate. A barrier material for preventing adhesions in a subject is further provided, including a preformed or in situ formable barrier substrate and a collagen inhibitor on or in the substrate. An ointment comprising a collagen inhibitor is further provided. Kits comprising the coated substrates are also provided. | 2009-01-29 |
20090028915 | Material having antimicrobial activity when wet - An article is applied to the surface of an article, animal housing environment or animal (including humans) to provide antimicrobial activity when activated with a liquid comprising alcohol. The article may comprise a water and/or alcohol absorbent material; and a composition that reacts with water and/or alcohol to produce molecular iodine. The composition provides a local concentration (in the water and/or alcohol) of at least 5 or 10 parts per million iodine in water and/or alcohol carried by the material (that is actual water supported by the water absorbent material) when the material has 5% by weight of water present in the water absorbent. | 2009-01-29 |
20090028916 | Loaded Microspheres - The invention relates to loaded microspheres with a mean diameter of 0.001 to 1 mm, and loaded with one or more absorbed or adsorbed active principles, which are obtained by mixing fine-particle polymethyl methacrylate or methyl methacrylate cross polymer with lipophilic or hydrophilic active principles until they have been absorbed or adsorbed by the surface of the polymer and a dry powder, granules or a paste is obtained. When applied to textile or fiber finishing, the loaded microspheres provide extended release of active cosmetic or pharmaceutical active principles. | 2009-01-29 |
20090028917 | Micronized Wood Preservative Formulations - The present invention provides wood preservative compositions comprising micronized particles. In one embodiment, the composition comprises dispersions of micronized metal or metal compounds. In another embodiment, the wood preservative composition comprises an inorganic component comprising a metal or metal compound and organic biocide. When the composition comprises an inorganic component and an organic biocide, the inorganic component or the organic biocide or both are present as micronized particles. When compositions of the present invention are used for preservation of wood, there is minimal leaching of the metal and biocide from the wood. | 2009-01-29 |
20090028918 | Gynecological pharmaceutics- containing microspherical vascular suppository of sodium alginate and its preparation method - The present invention relates to a kind of sodium alginate microsphere vascular embolus containing gynecological drug and its preparation. The preparation of it consists of the following steps: preparing the solution of gynecological drug, sodium alginate and dilvalent metal cations such as BaCl | 2009-01-29 |
20090028919 | SYSTEMS AND METHODS OF PROMOTING ENGRAFTMENT OF A HYBRID LOWER LIMB ARTERY BYPASS VASCULAR GRAFT IN A MAMMAL - Hybrid synthetic grafts and embodiments of systems and methods for producing hybrid vascular grafts that can yield implantable grafts that combine synthetic grafts with living cells. Embodiments of systems can include a pressure/flow loop subsystem having an external flow loop system coupled to a specimen holder, where the pressure/flow loop subsystem is capable of adjusting at least two dynamic conditions in the specimen holder or a diameter of a specimen in the specimen holder. Embodiments of methods can promote engraftment of a hybrid lower limb artery bypass vascular graft following implantation into a mammal's body by placing the hybrid lower limb artery bypass vascular graft in a system embodiment according to the invention prior to implantation of the hybrid lower limb artery bypass vascular graft into the mammal's body. | 2009-01-29 |
20090028920 | UROLOGICAL DEVICES INCORPORATING COLLAGEN INHIBITORS - Provided herein are implantable or insertable biomedical devices comprising a substrate and a collagen inhibitor on or in said substrate, and methods of treatment using the same. In some embodiments, the device is a urethral, ureteral, or nephroureteral catheter or stent. Kits comprising the same are also provided. | 2009-01-29 |
20090028921 | Electrospun Ceramic-Polymer Composite As A Scaffold For Tissue Repair - The present invention relates to compositions and methods of preparing a three-dimensional matrix of micron sized electrospun fibers, wherein the electrospun fibers are formed from a electrospun composite comprising a bioactive ceramic component and a polymer component. The matrix provides an osteoconductive and osteoinductive scaffold supporting osteogenesis and thereby facilitates bone repair. | 2009-01-29 |
20090028922 | Local Delivery Method and Composition - This invention provides a rapidly degrading composition for local delivery of a medicament, such as, an antibiotic. Additionally, this invention provides a method that can be used on the battlefield to deliver antibiotics as a preliminary treatment through the use of a rapidly degrading composition. | 2009-01-29 |
20090028923 | Implantable Devices and Methods for Treating Sinusitis and Other Disorders - Devices, systems and methods for stenting, spacing, draining, ventilating and/or delivering drugs and other therapeutic or diagnostic substances to desired locations within the bodies of human or non-human animal subjects, including methods and systems for treating paranasal sinusitis and ethmoid disease. | 2009-01-29 |
20090028924 | USE OF A POLYSACCHARIDE WHICH IS EXCRETED BY THE VIBRIO DIABOLICUS SPECIES FOR THE REGENERATION AND PROTECTION OF THE PERIODONTIUM - The invention relates to the use of a polysaccharide which is excreted by the | 2009-01-29 |
20090028925 | Novel Phosphinic Acid-Containing Thyromimetics - The present invention relates to compounds of phosphonic acid-containing T3 mimetics and monoesters thereof, stereoisomers, pharmaceutically acceptable salts, co-crystals, and prodrugs thereof and pharmaceutically acceptable salts and co-crystals of the prodrugs, as well as their preparation and uses for preventing and/or treating metabolic diseases such as obesity, NASH, hypercholesterolemia and hyperlipidemia, as well as associated conditions such as atherosclerosis, coronary heart disease, impaired glucose tolerance, metabolic syndrome x and diabetes. | 2009-01-29 |
20090028926 | Method and mixture for in vivo photochemical cross-linking of collagen - A method and a composition for photochemical cross linking of collagen by photoactive agent in-vivo are presented. The method includes a non-toxic photoactive formulation of the composition with collagen, which is administered to treatment area locally; followed by irradiation with suitable wavelength. In one of the embodiment liposomal formulated mTHPC is added to the collagen and is irradiated with a 652 nm laser, resulting in producing efficient collagen scaffolds with strengthen and stabilized microstructure, thus improving the physiochemical properties of the collagen scaffold. It improves the thermostability, mechanical property and swelling ratio of newly formed scaffold. Photochemical cross-linked collagens shows antimicrobial effect, when irradiated with suitable wavelength it disinfects the treatment site and curbs microbial growth. | 2009-01-29 |
20090028927 | POLY(VINYL ALCOHOL) - BACTERIAL CELLULOSE NANOCOMPOSITE - Hydrogel-bacterial cellulose nano-composite materials are created using a hydrogel and never dried bacterial cellulose fibers. Such materials are suitable for a broad range of soft tissue replacement applications. In addition controlled release of bioactive agents properties can be designed into medical devices fabricated from such composite materials. | 2009-01-29 |
20090028928 | Patch and patch preparation - The present invention aims to provide a patch and a patch preparation that do not require an acrylic polymer, and are capable of maintaining a large amount of an organic liquid component in an adhesive layer. | 2009-01-29 |
20090028929 | Transdermal Patch - A transdermal patch suitable for the administration of nitroglycerin. | 2009-01-29 |
20090028930 | BRUISE AMELIORATION COMPOSITION AND METHOD OF USE - A bruise amelioration composition that can be applied for one hour to an affected site, such as a bruise, contusion or blister, in the form of a gel, liquid or adhesive bandage. The composition includes at least 40% by weight of glycerin and at least 2% by weight of primrose oil. Preferably, the composition includes a fragrance, such as peach oil and marjoram and 1% to 10% by weight of vitamins A, C, D, E and K. | 2009-01-29 |
20090028931 | Liposomal compositions for parenteral delivery of agents - The invention provides methods and compositions for loading an agent, such as econazole, onto a liposome for parental delivery. The loading of the agent into a liposome comprises combining the agent with a micelle-forming compound to form a micelle including the agent, where the agent is releasable from the micelle-forming compound, and adding the micelle to the liposome, where the micelle combines with the liposome such that the agent is loaded into the liposome to form a loaded liposome. The methods are suitable for the loading of poorly soluble agents onto liposome. | 2009-01-29 |
20090028932 | VACCINE FORMULATIONS FOR LEISHMANIA - The present invention involves the use of | 2009-01-29 |
20090028933 | COMPOSITIONS AND METHODS FOR TREATING LYMPHOMA - The present invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of leukemias, including acute lymphoblastic leukemia (ALL). These methods involve the administration of liposome-encapsulated vinca alkaloids, e.g., vincristine, in combination with dexamethasone to a mammal with a leukemia. | 2009-01-29 |
20090028934 | GRANULAR, GASTRO-RESISTANT PRODUCT BASED ON NIACIN OR DERIVATES THEREOF AND PROCESS FOR THE PRODUCTION OF SUCH A PRODUCT - A granular, gastro-resistant product based on niacin or derivatives thereof comprises an internal part in which the niacin is substantially concentrated and an external coating, provided to cover and protect the internal part, made up of a matrix having a total weight fraction of long-chain C16-C22 saturated fatty acids of between 40% and 95% relative to the matrix. A process for the production of such a granular product is also described. | 2009-01-29 |
20090028935 | CARVEDILOL FORMS, COMPOSITIONS, AND METHODS OF PREPARATION THEREOF - Disclosed are amorphous carvedilol salt forms, controlled-release carvedilol compositions, and methods of preparing the forms and compositions. | 2009-01-29 |
20090028936 | Tablets containing enrofloxacin and flavouring agents and/or flavours - The present invention relates to tablets for animals, which tablets comprise enrofloxacin as well as flavourings and/or aromatizing substances. | 2009-01-29 |
20090028937 | TABLET COMPRISING ORNITHINE HYDROCHLORIDE - The present invention has an object to provide a tablet capable of comprising ornithine hydrochloride in a higher content; and a process for producing the same, and provides the tablet comprising ornithine hydrochloride and maltose, or a linear or cyclic dextrin; and the process for producing a tablet comprising ornithine hydrochloride, which comprises compression molding a mixture comprising ornithine hydrochloride and maltose, or a linear or cyclic dextrin by a direct tableting method. | 2009-01-29 |
20090028938 | DOSAGE FORMS WITH IMPROVED BIOAVAILABILITY - A solid dispersion product comprising an effective amount of one or more active ingredients and an effective amount of one or more hydroxypropyl methylcellulose(s), which satisfies the Formula 0.35>ΔH | 2009-01-29 |
20090028939 | Solid Preparation - The present invention intends to provide a solid preparation which contains an insulin sensitizer and an active ingredient other than an insulin sensitizer, and exhibits dissolution behavior of an insulin sensitizer similar to that of an insulin sensitizer from “a solid preparation containing only an insulin sensitizer as an active ingredient”. The solid preparation comprises “a part containing coated particles in which the particles containing an insulin sensitizer are coated with lactose or a sugar alcohol” and “a part containing an active ingredient other than an insulin sensitizer”. | 2009-01-29 |
20090028940 | PHARMACEUTICAL COMPOSITIONS OF RIFAXIMIN - A pharmaceutical composition comprising therapeutically effective amount of rifaximin or pharmaceutically acceptable salt or enantiomer or polymorph thereof, pharmaceutically acceptable excipient(s) and release controlling agent(s). Pharmaceutical composition of rifaximin comprising: at least two entities wherein one entity is an immediate release or fast release and the other is controlled release. The pharmaceutical composition in the form of multilayer tablet comprising, at least one layer comprising, therapeutically effective amount of rifaximin or pharmaceutically acceptable salt or enantiomer or polymorph thereof, pharmaceutically acceptable excipient(s); said layer providing controlled release rifaximin; and at least one layer which provides increased residence time of the dosage form in the gastrointestinal tract. The pharmaceutical formulation comprising rifaximin having an in vitro dissolution profile, wherein about 70% of rifaximin is released in about 24 hours. The composition comprising therapeutically effective amount of rifaximin or pharmaceutically acceptable salt(s) or enantiomer(s) or polymorph(s) thereof, one or more release controlling agent(s) and pharmaceutically acceptable excipient(s) causing pathogenic eradication. | 2009-01-29 |
20090028941 | Pulsatile gastric retentive dosage forms - Dosage forms for delayed and pulsed release of therapeutic agents into the stomach are described. The dosage forms are gastric retentive dosage forms that achieve release of the therapeutic agent into the stomach and upper gastrointestinal tract subsequent to administration of the dosage form. The dosage forms find particular use in administration of acid-labile active agents such as proton pump inhibitors, and in treating gastric acid secretion such as gastro-esophageal reflux disease (GERD) and nocturnal acid breakthrough (NAB). | 2009-01-29 |
20090028942 | Sustained release compositions of alfuzosin - The invention relates to sustained release compositions of alfuzosin or pharmaceutically acceptable salts thereof that include one or more functional layers. The functional layer includes alfuzosin or pharmaceutically acceptable salts thereof and one or more pharmaceutically acceptable hydrophilic and/or hydrophobic rate-controlling polymers. | 2009-01-29 |
20090028943 | PHARMACEUTICAL COMPOSITIONS - Pharmaceutical compositions comprising AZD2171 or a pharmaceutically acceptable salt thereof, including pharmaceutical compositions comprising AZD2171 or a pharmaceutically acceptable salt and a plastic filler with a high surface area, excluding lactose. | 2009-01-29 |
20090028944 | PHARMACEUTICAL COMPOSITIONS COMPRISING MESALAMINE - Pharmaceutical compositions comprising mesalamine, wherein the compositions are free of a liphophilic matrix, and processes for preparing pharmaceutical compositions comprising mesalamine and being free of a liphophilic matrix. | 2009-01-29 |
20090028945 | Immunoisolative encapsulation system - A fundamental deficiency with current biological cell encapsulation technology is that passive material barriers cannot protect biological cells from exposure to cytokines and other small, diffusible cytotoxic molecules produced by activated immune cells, subsequently leading to biological cell destruction. The present invention provides an immunoisolative encapsulation system that actively and locally suppresses immune response using Fas receptor binding agents. | 2009-01-29 |
20090028946 | Photo-responsive delivery system - A photo-responsive delivery system useful to deliver a compound to a target site is provided. The system includes a physiologically compatible matrix crosslinked with a photo-responsive matrix cross-linking agent. A method of making the delivery system and a method of delivering a compound to a target site using the system are also provided. | 2009-01-29 |
20090028947 | USING OF NANOSILVER IN POULTRY, LIVESTOCK AND AQUATICS INDUSTRY - Nanosilver material is disclosed. Said material is nano silver based disinfectant and disease preventer for poultry, livestock and aquatics. The material contains silver nano particle and pure water and can be used as a surface disinfectant, water disinfectant and therapentic material for poultry, livestock and aquatic disease caused by bacteria's viruses, fungi and other monocellular microorganism. | 2009-01-29 |
20090028948 | NANOPARTICLE COMPOSITION AND METHODS OF SYNTHESIS THEREOF - The present invention relates to improved therapeutically active nanocomposite microstructure compositions, including nanoparticle compositions and nanoparticle preparations. Preferred embodiments include nanoparticle compositions comprising nanoparticles of a therapeutically active agent dispersed in a carrier matrix. The invention also relates to a method for preparing said compositions and preparations using solid-state mechanochemical synthesis. Further, it relates to therapeutic products produced using said compositions and to methods of treatment using the compositions. | 2009-01-29 |
20090028949 | CALCIUM PHOSPHATE-BASED ADHESIVE FORMULATION FOR BONE FILLING WITH SWELLING PROPERTIES - The present invention relates to a calcium phosphate-based formulation for bone filling, comprising at least one adjuvant giving adhesion properties, said at least one adjuvant can be selected from the sugar and sugar derivative group. | 2009-01-29 |
20090028950 | GRANULE DISPERSION COMPOSITION, PROCESS FOR PRODUCING THE SAME, AND GRANULAR MATERIAL AND MEDICINE - The subject matter of the present invention is to provide a new particulate material dispersion composite in which a material poorly soluble in water is micronized and dispersed. For the above purpose, a particulate material dispersion composite is produced in the present invention, wherein a particulate material containing a specific material which is poorly soluble in water, a polymer and a lipid is dispersed in water, the mean diameter of said particulate material is 1 μm or less, and the ratio of the combined weight of said polymer and said lipid to the weight of said specific material is 1.5 or larger. | 2009-01-29 |
20090028951 | Compositions for Oral Administration of Sustained Release Glutathione, Methods for Their Production and Uses Thereof - A composition suitable for oral administration for sustained-release of glutathione, the composition having from about 50% by weight to about 90% by weight glutathione; from about 0% by weight to about 10% by weight binder; from about 10% by weight to about 50% by weight of at least one sustained release agent; and a granule size of from about 850 μm to about 5000 μm, is provided. Methods for preparing such compositions are also provided. Uses and methods of medical treatment by orally administering a composition for sustained release of glutathione to a patient suffering from or at risk of suffering from a neurological disorder are also provided. | 2009-01-29 |
20090028952 | Hydroxy sulfonate of quinone compounds and their uses - The present invention provides sodium 6-hydroxy-2,2-dimethyl-5-oxo-3,4,5,6-tetrahydro-2H-benzo(h)chromene-6-sulfonate, and its synthesis and uses in the treatment of cancer. | 2009-01-29 |
20090028953 | METHOD OF TREATMENT USING MICROPARTICULATE BIOMATERIAL COMPOSITION - Compositions of microspheres formed of stabilized hyaluronic acid are disclosed. The unique biological properties of hyaluronic acid provide for very inert properties when exposed to tissues. Microsphere formulations of hyaluronic acid have medical utility due to the resultant properties of flowability, physical stability, and degradability. High concentration formulations of the microspheres have utility when injected to form a localized mass within tissues by providing physical stability and anti-fibrotic biological activity, especially suitable for certain surgical reconstructions. Low concentration formulation of the microspheres of the appropriate size range have utility when injected into the blood system to delivery diagnostic and therapeutic compounds. | 2009-01-29 |
20090028954 | PRECURSOR FOR THE PREPARATION OF A PASTY BONE REPLACEMENT MATERIAL BY ADMIXTURE OF A LIQUID - The precursor is used for the preparation of a pasty bone replacement material by admixture of a liquid. The precursor comprises a biocompatible substance swellable by the action of water or of an aqueous solution thereby forming a hydrogel; and solid particles made of a substance which is suitable as a bone replacement material. The swellable substance is in the form of discrete particles having a mean dimension in the range of 18 μm to 2000 μm. | 2009-01-29 |
20090028955 | Ophthalmic emulsions containing an immunosuppressive agent - Ophthalmic oil-in-water emulsions, which comprises colloid particles having an oily core surrounded by an interfacial film, the emulsion comprising an 10 immunosuppressive agent, an oil, preferably at least 50% of which being MCT, and tyloxapol. Use of such an emulsion for the manufacture of medicament for treatment of eye conditions, particularly of dry eye diseases. | 2009-01-29 |
20090028956 | Polypeptide microparticles - The invention provides polypeptide microparticles and methods for the preparation thereof using a nucleating agent. | 2009-01-29 |
20090028957 | Implantable Tissue-Reactive Biomaterial Compositions and Systems, and Methods of Us Thereof - The invention pertains to biomaterial compositions and implantable systems for application to a tissue site in a living mammalian body. The compositions and systems react with tissue surfaces and components present in physiological fluids at the region of implantation, obviating the need to remove such fluids and improving the adhesion and resorption rate of the resulting bioimplant. Delivery devices and methods of use are also provided. | 2009-01-29 |
20090028958 | Cosmetic Makeup and/or Care Process - The present invention relates mainly to a cosmetic process for making up and/or caring for keratin material(s), comprising the application, on contact with a keratin material, of at least one cosmetic composition comprising at least 75% by weight, relative to its total weight, of compound(s) approved for food use and having a gloss value at least greater than or equal to about 5. | 2009-01-29 |
20090028959 | PHARMACEUTICAL COMPOSITION AND METHOD FOR REGENERATING MYOFIBERS IN THE TREATMENT OF MUSCLE INJURIES - A pharmaceutical composition and method for regenerating cardiomyocytes in treating or repairing heart muscle damages or injuries caused by an ischemic disease. The pharmaceutical composition contains an active ingredient compound with a backbone structure of Formula (I). The active ingredient compound is capable of (a) increasing viability of myogenic precursor cells to enable said precursor cells to survive through an absolute ischemic period; (b) reconstituting a damaged blood supply network in said heart region where said injured muscle is located; and (c) enhancing cardiomyogenic differentiation efficiency of said precursor cells down cardiac linage, said steps being performed simultaneously or in any particular order. | 2009-01-29 |
20090028960 | CALCIUM PHOSPHATE-BASED ADHESIVE FORMULATION FOR BONE FILLING - The present invention relates to a calcium phosphate-based formulation for bone filling, comprising at least one adjuvant giving adhesion properties, said at least one adjuvant can be selected from the saccharide head surfactant group. | 2009-01-29 |
20090028961 | Decontamination solution and its use for denaturation, modification, degradation, solubilisation and removal of proteins, nucleic acid molecules and microorganisms - The invention concerns a three component system comprising surface-active substances, vitamins and metal ions for efficient destruction and removal of contaminating proteins, nucleic acids and microorganisms from surfaces like for example laboratory benches, floors, equipment and instruments. These non-corrosive and non-toxic solutions for removal of proteins, nucleic acids and microorganisms are applied by spraying, rubbing or immersion of contaminated surfaces thereby destroying, solubilizing inactivating and removing proteins and nucleic acids. In that way also microorganisms are killed with high efficiency and at the same time all genetic information is inactivated. | 2009-01-29 |
20090028962 | Methods and Compositions for Enhancing Iron Absorption - The present invention generally relates to methods and compositions useful in enhancing iron absorption in a patient. The methods and compositions of the present invention may be used independently to promote and/or maintain iron absorption in a patient or may be used in combination with one or more other compositions used in the treatment of one or more diseases having iron deficiency associated therewith. | 2009-01-29 |
20090028963 | Polyphenol Coxib Combinations and Methods - Contemplated compositions and methods utilize a combination of a polyphenol and a non-polyphenol cyclooxygenase-2 inhibitor. Preferably, the compositions are pharmaceutical and/or nutraceutical compositions and formulated in a dosage form and amount such that the polyphenol and the non-polyphenol cyclooxygenase-2 inhibitor are effective to reduce tumor incidence and/or multiplicity. In preferred aspects, the polyphenol is epigallocatechin gallate, epigallocatechin, epicatechin gallate, epicatechin, and/or a mixture of polyphenols isolated from a plant (e.g., polyphenon E), and the cyclooxygenase-2 inhibitor is rofecoxib, celecoxib, and/or valdecoxib. | 2009-01-29 |
20090028964 | CONTAINER AND KIT FOR THE PREPARATION, STORAGE AND DISPENSING OF COMPOUNDED SUPPOSITORIES - A container suitable for the preparation, storage and dispensing of compounded suppositories is provided. Methods of preparing, storing and dispensing compounded suppositories utilizing such a container and related kits are also provided. | 2009-01-29 |
20090028965 | MULTI-PART DISINFECTANT - Disclosed is a multi-part disinfectant composition, wherein the parts thereof are solid and are packaged separately prior to use, and wherein the separately-packaged parts, when combined in the presence of water or an aqueous solution, react to form chlorine dioxide. | 2009-01-29 |
20090028966 | Methods for Introducing Reactive Secondary Amines Pendant to Polymers Backbones that are Useful for Diazeniumdiolation - Biocompatible polymers having polymer backbones with at least one secondary amine suitable for diazeniumdiolation are disclosed. Specifically, methods for providing secondary amines-containing polymers using epoxide-opening reactions are provided. More specifically, nitric oxide-releasing medical devices made using these polymers are disclosed. | 2009-01-29 |
20090028967 | FLUID KONJAK MATERIAL AND ITS PRODUCTION AND USE - A fluid konjak material, which can be mixed with any other edible material uniformly at a high concentration while sufficiently keeping the gelling power and the biological effect intrinsic to konjak mannan, is provided by swelling and dissolving konjak flour in water, treating the resultant with alkali at a pH of at least 10, lowering the pH to less than 8, heating the composition with forced stirring and enzymatically treating the forcedly-stirred composition. | 2009-01-29 |
20090028968 | Pharmaceutical Platform Technology for the Development of Natural Products - The present invention provides a set of in vitro and in silico methodologies for predicting in vivo pharmacokinetics and pharmacodynamics of multiple components; the methodologies comprise mathematical models for solving multiple unknowns which are linearly independent and/or interacting with each other. The present invention can be applied to develop phytomedicines which contain multiple active ingredients without prior identification, isolation and purification of these components. | 2009-01-29 |
20090028969 | Compostion for treating skin - A combination comprising verbascoside and luteolin, and its use in a cosmetic or pharmaceutical composition for pigmentation modulation. | 2009-01-29 |
20090028970 | ANTIALLERGIC COMPOSITION - It is an object of the present invention to provide an antiallergic composition that is moderate for the human body and skin, and has reduced side-effects. In order to achieve this object, there is provided the antiallergic composition comprises a cold-water extract from hop tissue or flavonoid glucosides separated from the cold-water extract from hop tissue. | 2009-01-29 |
20090028971 | Method for Obtaining Natural Oils From Plant Constituents - The invention relates to a method for obtaining natural oils from plant constituents, said method being essentially carried out using compressed C | 2009-01-29 |
20090028972 | Treating Neoplasms With Neurotoxin - The present invention provides a method of treating a cancer using a neurotoxin, preferably Botulinum toxin (“BTX”). The application of a neurotoxin around a cancer acts to decrease the contractile forces of the muscles surrounding a neoplasm which normally squeeze cancer cells through efferent channels leaving the cancer vicinity to distant sites. Also, the application of the toxin at sites distant from the cancer enhances cellular and humoral immunologic functions which further contributes to cancer cell death and spread. Following administration of botulinum toxin around and distant to a cancer, it is noticed that local, regional, and distant spread is reduced or eliminated. Immunomodulation with botulinum toxin is also valuable in treating other disease that may or may not be associated with cancers, such as viral-induced growths, viral conditions, fungal disease, chronic wounds, graft versus host disease, autoimmune disease, and HIV. | 2009-01-29 |
20090028973 | Use Of Nocardia Rubra Cell Wall Skeleton In The Preparation Of Anti-HPV Infection Medicaments - The invention refers to use of | 2009-01-29 |
20090028974 | Use of Botulinum Toxin Therapy for Treatment of Recalcitrant Voiding Dysfunction - The present invention related to methods for treating neurological-urological conditions. This is accomplished by administration of at least one neurotoxin. | 2009-01-29 |
20090028975 | Method and apparatus for making crystalline pet pellets - A method and apparatus for underwater pelletizing and subsequent drying of polyethylene terephthalate (PET) polymers and other high temperature crystallizing polymeric materials to crystallize the polymer pellets without subsequent heating. High velocity air or other inert gas is injected into the water and pellet slurry line to the dryer near the pelletizer exit. Air is injected into the slurry line at a velocity of from about 100 to about 175 m | 2009-01-29 |
20090028976 | Height-Adjustable Molding Device for Molding Thermoplastic Recipients of Various Heights - The invention relates to a moulding device for blowing thermoplastic recipients of various heights, said device comprising a mould provided with two mould halves and a mould bottom which are mutually mobile. Each mould half comprises a mould carrier, a chill carrier and a chill, said two chills and the mould bottom comprising mould impressions, which together define a moulding cavity. The inventive device also comprises means for compensating the blowing pressure, said means being provided between a mould carrier and the associated chill carrier. For recipients with the maximum height, the chill carriers and chills are the same height. For lower recipients, the chills are lower than the chill carriers and radially reinforcing means are provided on the internal faces of the carriers in the parts thereof which do not co-operate with the chills. | 2009-01-29 |
20090028977 | Extrusion Method and Extrusion Device - Material is extruded with a device comprising at least two stators ( | 2009-01-29 |
20090028978 | Extruder with Feed-Back Means | 2009-01-29 |
20090028979 | HONEYCOMB STRUCTURE BODY MOLDING DIE - A honeycomb structure body molding die is disclosed including a die main body, having a feed bore section and a slit recess section, and a guide ring having an upright support section and a guide section carried on the upright section, which includes a stepped section and has a central slit recess forming section, provided on the stepped section, and an outer circumferential slit recess forming surface. The die main body has a non-opposing region, formed on an area outside the stepped section, in which the outer circumferential slit recess forming surface does not axially face the guide section, while having a feed bore closing region closing the feed bores. The die main body has outer circumferential-skin forming material feed passages formed in an area outside the feed bore closing region for feeding the molding material to a squeezing outlet for forming an outer circumferential skin. | 2009-01-29 |
20090028980 | EXTRUSION DIE FOR MOLDING HONEYCOMB STRUCTURES - An extrusion die is used for producing a honeycomb structures. The extrusion die is composed of a guide ring and a die body part. Feeding holes and slit grooves are formed in the die body part. The guide ring has a pole part and a guide part. A slit groove formation area has a central slit groove formation surface area having a step shaped part and an outer peripheral slit groove formation area. An angle of the step-shaped part to an outer slit groove formation surface is within a range of 90°≦α≦95°, and a relationship A≦B<1.5 A is satisfied, where A is a gap between the outer peripheral slit groove formation surface to the guide part, and B is a gap between the outer peripheral side surface of the step shaped part and the front end of the guide part. | 2009-01-29 |
20090028981 | HONEYCOMB STRUCTURE BODY MOLDING DIE - A honeycomb structure body molding die for molding a honeycomb structure body having cells walls, a large number of cells surrounded with the cells walls, and a cylindrical outer circumferential skin is disclosed as including a die main body having material feed bores and slit recesses, and a guide ring. The guide ring has a guide section having an opposing guide surface, facing a slit recess forming surface of the die main body, which has an annular circumferential area formed with a pool recess, concaved from the opposing guide surface in an extruding direction, which is formed with a slanted surface tapered at an inclining angle β satisfying the relationship expressed as 10°—β≦20° so as to decrease in depth as an inner radial end of the pool recess slanted surface approaches the guide end of the guide section. | 2009-01-29 |
20090028982 | EXTRUSION DIE FOR MOLDING HONEYCOMB STRUCTURES - An extrusion die for use of producing a honeycomb structure composed of cells surrounded by cell walls and an outer peripheral skin. The extrusion die has a die body part and a guide ring. Feeding holes and corresponding slit grooves are formed in the die body part. The guide ring has a pole part and a guide part. The specified feeding holes which are not correspond to any slit grooves are formed in the outside area of a slit groove formation area in the die body part. Through the specified feeding holes, raw material is fed in order to make the outer peripheral skin. The specified feeding holes are arranged in one or more ring-shaped rows. Each specified feeding hole in each ring-shaped row has a same distance to the front end of the guide part in the direction vertical to the extrusion direction of the raw material. | 2009-01-29 |
20090028983 | Injection mold with a tie bar - The injection mold with a tie bar includes an upper stationary board, a stripping plate, a female board, a male board and a lower stationary plate from top to bottom. The upper stationary plate extends outward to form a projection plate, an accepting hole opened in the projection plate and having a step therein. A tie bar is arranged on the outside of the injection mold and includes a stud, a connecting head and a pole. The stud passes through the accepting hole and is fixed on the top of the pole. The stud is slidable along the accepting hole and against the step. The top of the pole is located the outside of the stripping plate while the bottom extends outward to form at least one block. The connecting head has a gap for encircling the pole and is slidable along the pole and against the block of the pole. | 2009-01-29 |
20090028984 | Transition Channel For Use Between A First Conduit And A Second Conduit In A Molding System - Disclosed herein is a transition channel for conveying fluid between a first conduit and a second conduit in a molding system. For example, there is disclosed a transition channel for providing a flow path between a first conduit having a first cross-section and a second conduit having a second cross-section in a molding system, the transition channel configured to have a shape that follows a curve that substantially corresponds to melt natural stream lines. | 2009-01-29 |
20090028985 | Baffle for Coolant Passages in Plastic Injection Molds - An baffle plug comprising a base and a blade extending therefrom. The baffle plug is used in a bore to divide the bore into longitudinally extending passages and cause the liquid to flow serially back and forth through the bore. The blade may comprise various fluid directing structures providing for efficient fluid flow across the surfaces of the blade. The blade may also comprise one or more structures which create turbulent flow of the fluid flowing across the surface of the blade. | 2009-01-29 |
20090028986 | INJECTION MOLDING FLOW CONTROL APPARATUS AND METHOD - Apparatus for controlling the rate of flow of fluid material through an injection molding flow channel leading to a mold cavity, the apparatus comprising:
| 2009-01-29 |
20090028987 | Sliding Valve for an Injection Nozzle - A shut-off valve assembly for an injection unit is provided. It includes a first valve body, defining a portion of a channel, and a second valve body, defining a second portion of the channel, the second valve body being slidable relative to the first valve body. A plunger having an orifice therethrough, is located between the first valve body and the second valve body, and is selectively movable between an open position where the orifice is aligned with the channel and a closed position where the orifice is misaligned with the channel. Compressing the first valve body and the second valve body together while the plunger is in the open position creates a positive face seal around the orifice, thereby reducing leakage in the shut-off valve assembly. | 2009-01-29 |
20090028988 | Injection-Moulding Apparatus with Needle Valve Nozzle - An injection molding apparatus ( | 2009-01-29 |
20090028989 | Process for the Production of Phospholipids - The present invention provides a phospholipid composition obtainable by a process comprising contacting a fish meal with an organic solvent to produce a lipid-containing liquid, and subjecting said liquid to microfiltration optionally followed by solvent stripping. | 2009-01-29 |
20090028990 | Food composition for stimulating growth comprising fraction isolated from mammalian colostrum or milk whey - The present invention relates to a food composition for stimulating growth, comprising a fraction isolated from whey derived from mammalian colostrum or milk. More particularly, the present invention relates to a food composition for stimulating growth, comprising a fraction isolated from mammalian whey, wherein the fraction was removed α-lactoalbumin and β-lactoglobulin from the whey and had a molecular weight of 1-30 kD, as well as a method for stimulating growth, which comprises administering the food composition to mammals in need thereof, and a use of the isolated fraction for preparing the growth-stimulating food composition. | 2009-01-29 |
20090028991 | Lactobacillus buchneri strain LN1284 and its use to improve aerobic stability of silage - A method for treating silage to enhance aerobic stability by inhibiting growth of microorganisms selected from yeasts, molds and spore-forming bacteria is disclosed. The method comprises treating silage or feed with a composition comprising | 2009-01-29 |
20090028992 | Lactobacillus buchneri strain LN1286 and its use to improve aerobic stability of silage - A method for treating silage to enhance aerobic stability by inhibiting growth of microorganisms selected from yeasts, molds and spore-forming bacteria is disclosed. The method comprises treating silage or feed with a composition comprising | 2009-01-29 |
20090028993 | Lactobacillus buchneri strain LN1326 and its use to improve aerobic stability of silage - A method for treating silage to enhance aerobic stability by inhibiting growth of microorganisms selected from yeasts, molds and spore-forming bacteria is disclosed. The method comprises treating silage or feed with a composition comprising | 2009-01-29 |
20090028994 | USING MUTATIONS TO IMPROVE ASPERGILLUS PHYTASES - The present invention relates to an isolated nucleic acid molecule encoding a mutant phytase and the isolated mutant phytase itself. The present invention further relates to methods of using the isolated nucleic acid molecule and the isolated mutant phytase of the present invention. | 2009-01-29 |
20090028995 | Animal feed with a soluble fiber and sugar alcohol and method of making and method of feeding - An animal feed such as a milk replacer includes a soluble fiber and a sugar alcohol. The milk replacer enhances weight gain, starter intake and reduces weaning time. The method of feeding the animal includes feeding a mixture of a soluble fiber and sugar alcohol. The animal feed may be used as a method of weaning young ruminants such as calves. | 2009-01-29 |
20090028996 | METHODS FOR REDUCING FOOD INTAKE AND CONTROLLING THE WEIGHT OF ANIMALS - Methods for reducing food intake by and controlling the weight of an animal by feeding the animal a composition comprising a food intake reducing amount or a weight controlling amount of a soluble fiber. | 2009-01-29 |
20090028997 | Peptide pet food material having anti-stress action and palatability-increasing effect - The present invention provides a safe pet food material having an anti-stress action and effect of increasing palatability. Livestock meat or fish meat is treated with a protease such as papain to obtain a pet food material with excellent thermal stability having peptides consisting of 2-10 amino acid residues as a principal active ingredient. A pet food exhibiting an anti-stress action and having high palatability is obtained by blending this material. | 2009-01-29 |
20090028998 | MULTI-REGION CHEWING GUM COMPOSITION INCLUDING SATURATED PARTICULATE POLYOLS - The present invention relates to chewing or bubble gum compositions that include a first region composition and a second, or gum, region adjacent to or surrounding the first region. The first region composition may be a center-fill co-position, such as a liquid-fill composition. The second region includes a particulate polyol having a reduced particle size and which is saturated by a syrup material, such as a polyol syrup, glycerin or the like. The addition of the particulate polyol to the second region provides stability to the chewing gum, composition by reducing the problem of migration of the first region composition into the second region. The multi-region chewing gum composition also may include a coating region which surrounds or covers the second region. | 2009-01-29 |
20090028999 | Beer brewing kit and brewing method to prepare wort for the kit - A kit for home brewed beer which comprises a bottle, wort substantially filling the bottle, and a cap which has venting means to permit escape of gas from the bottle when pressure therein exceeds a predetermined value. There is also disclosed a brewing method wherein lactic acid is added to the wort to reduce the pH to level 4.6 and a predetermined amount of yeast is added to the wort to cause a short fermentation while maintaining the alcohol level below 0.5% by volume. | 2009-01-29 |
20090029000 | Barley for Production of Flavor-Stable Beverage - According to the invention, there is provided null-LOX-1 barley and plant products produced thereof, such as malt manufactured by using barley kernels defective in synthesis of the fatty acid-converting enzyme lipoxygenase-1. Said enzyme accounts for the principal activity related to conversion of linoleic acid into 9-hydroperoxy octadecadienoic acid, a lipoxygenase pathway metabolite, which-through further enzymatic or spontaneous reactions may lead to the appearance of trans-2-nonenal. The invention enables brewers to produce a beer devoid of detectable trans-2-nonenal-specific off flavors, even after prolonged storage of the beverage. | 2009-01-29 |
20090029001 | GENE ENCODING PROTEIN RESPONSIBLE FOR FLOCCULATION PROPERTY OF YEAST AND USE THEREOF - The present invention relates to a gene encoding a protein responsible for flocculation property of yeast and use thereof, in particular, a brewery yeast with appropriate flocculation property for producing desired alcoholic beverages, alcoholic beverages produced with said yeast, and a method for producing said beverages. More particularly, the present invention relates to a yeast to which suitable flocculation property for brewing desired alcoholic beverages was imparted by controlling expression level of KRE9 gene encoding a protein responsible for flocculation property of brewery yeast, especially non-ScKRE9 gene specific to a lager brewing yeast, to alcoholic beverages produced with said yeast and to a method for producing said beverages. | 2009-01-29 |
20090029002 | Gene encoding glycogen synthesis initiator and use thereof - The present invention relates to a gene encoding glycogen synthesis initiator and use thereof, in particular, a yeast for practical use with superior resistance property to dryness and/or low-temperature storage, alcoholic beverages produced with said yeast, and a method for producing said beverages. More particularly, the present invention relates to a yeast, whose resistance property to dryness and/or resistance property to low-temperature storage is enhanced by amplifying expression level of GLG1 or GLG2 gene encoding a Glg1p or Glg2p which is a glycogen synthesis initiator in brewer's yeast, especially non-ScGLG1 gene or non-ScGLG2 gene specific to a lager brewing yeast and to a method for producing alcoholic beverages with said yeast, etc. | 2009-01-29 |
20090029003 | Process for Tea Manufacture - The present invention provides a process for manufacturing a leaf tea product. The process comprises the steps of providing fresh tea leaf, recovering aroma from the fresh tea leaf, and drying the fresh tea leaf to form the leaf tea product. The aroma is recovered whilst at least partially drying the fresh leaf in a low-convection dryer. | 2009-01-29 |
20090029004 | PHYTASE VARIANTS - The present invention relates to phytase variants derived from a parent phytase which is homologous to a | 2009-01-29 |
20090029005 | Anti-Hypertensive Functional Food Products - The present invention provides novel protein hydrolysates with anti-hypertensive properties, as well as food products and food supplements comprising these. | 2009-01-29 |
20090029006 | Oral Cavity Stimulating Substance - A novel compound causing an oral cavity stimulus such as acridness, which is expressed by the following structural formula (I): | 2009-01-29 |
20090029007 | SOY-BASED AQUEOUS FOOD CONCENTRATE - The present invention relates to soy-based aqueous concentrated food composition which are stable to cooking conditions, i.e. do not undergo decomposition or separation upon prolonged heat and/or acid treatment. The invention also relates to the use of partially hydrolysed soy protein to improve the stability of said compositions' and to a method for preparing a stable soy-based concentrated food composition. | 2009-01-29 |
20090029008 | PROCESSES FOR ADHERING FOOD PARTICULATES TO DOUGH AND RELATED FOOD ITEMS - The present invention provides improved methods for producing crackers with food particulates adhered to the surface, as well as the crackers produced by the methods. The processes described result in crackers which retain more topping and reduce waste. Moreover, the processes provide optional lower-fat formulations of a sweetened, hand-held food. | 2009-01-29 |
20090029009 | SPORTS DRINK CONTAINING RICE SYRUP AND AGAVE NECTAR - An all natural beverage comprised of rice syrup, agave nectar, fruit juice and electrolytes. The beverage is useful for rapid hydration and replenishment of lost carbohydrates and electrolytes after exercise, physical exertion, or exposure to heat. | 2009-01-29 |
20090029010 | ORGANIC SPORTS DRINK CONTAINING RICE SYRUP AND AGAVE NECTAR - An organic beverage comprised of rice syrup, agave nectar, fruit juice and electrolytes. The beverage is useful for rapid hydration and replenishment of lost carbohydrates and electrolytes after exercise, physical exertion, or exposure to heat. | 2009-01-29 |
20090029011 | CHEESE BLOCK DESIGN - A cheese snack product comprising a block of cheese which has means to facilitate separation of the product into snack size portions. The means to facilitate separation may comprise areas of the block which are of lesser thickness than the remainder and these may be formed either by scoring or cutting into the surface of the block or by moulding the block to provide such portions. The block of the invention is preferably contained in a sealed package and a package which can be opened and then resealed is preferred. Also, it is possible to include in the package under the cheese a member which permits the cheese block to be readily moved outwardly from the package. The cheese block can comprise cheese of one or two or even more types so as to provide different flavours/textures for the product. | 2009-01-29 |
20090029012 | NON-TRANSPARENT, FAT-IMPERVIOUS FOOD CASING WITH TEXTILE BACKING MATERIAL - The invention relates to a tubular food casing with a textile backing material which is coated on the inside with a layer of regenerated or precipitated cellulose. This casing combines the properties of a textile skin with those of a cellulose fiber skin. Aside from the surface texture for which textile skins are known and prized, it features the water-vapor permeability, oxygen permeability and smoke-component permeability of a cellulose fiber skin. At the same time the casing is impervious to fats. It is used preferably as an artificial sausage casing. | 2009-01-29 |
20090029013 | DEVICE FOR PACKAGING AND COOKING KERNELS OF CORN FOR MAKING POPCORN - A device for packaging and cooking popcorn includes in the lower part an essentially rigid base, and in the upper part a compensating zone that can occupy a first folded position in which it forms a cover for the base and delimits a restricted volume, and a second unfolded position in which it forms a tube and delimits a larger volume suited to that of the cooked popcorn. The device is produced from a complex material that includes a layer made of cardboard-type material to ensure the rigidity and a layer that is made of flexible and airtight plastic that is placed on the surface oriented toward the inside of the device. The device includes a window at least at the level of a wall of the compensating zone, whereby the complex material does not have a layer that is made of cardboard-type material to the right of the window. | 2009-01-29 |